Dexmedetomidine, sold under the trade names Precedex among others, is an
anxiolytic, sedative, and analgesic medication. Similar to clonidine, it is an
Medscape - Indication-specific dosing for Precedex, (dexmedetomidine),
frequency-based adverse effects, comprehensive interactions, contraindications,
Learn about clinical pharmacology for the drug Precedex (Dexmedetomidine
J Pain Palliat Care Pharmacother. 2006;20(2):23-7. Dexmedetomidine: a novel
analgesic with palliative medicine potential. Jackson KC 3rd(1), Wohlt P, Fine PG
Effect of sedation with dexmedetomidine vs lorazepam on acute brain
dysfunction in mechanically ventilated patients: the MENDS randomized
Dexmedetomidine. Dex was developed in the 1990s by Orion and Abbott as a
sedative for use in the intensive care unit setting. In 1999, Abbott received FDA ...
Apr 12, 2016 ... Design, Setting, and Participants The Dexmedetomidine to Lessen ICU Agitation
(DahLIA) study was a double-blind, placebo-controlled, ...
Jun 13, 2005 ... Mechanism of action, Dexmedetomidine is a specific and selective alpha-2
adrenoceptor agonist. By binding to the presynaptic alpha-2 ...
Expect the same efficacy and safety profile as the brand. Putney's
Dexmedetomidine HCl is the first-to-market FDA approved generic equivalent of
Dexdomitor <sup>®</sup> ...
The recently described adrenoreceptor agonist dexmedetomidine has a half-life
of only 2.3 h, and is 8- to 10-fold more potent than clonidine for the α<sup>2</sup>receptor.